OBJECTIVES:
Understand the mechanism of immune response in patients with Covid-19
Understand the rationale of vaccine development
Know the vaccine candidates being developed
Shikha Bose, MD is Director of Cytopathology in the Department of Pathology and Laboratory Medicine at Cedars-Sinai. She is Professor of Pathology and Laboratory Medicine at Cedar Sinai Medical Center and at the David Geffen School of Medicine, University of California, Los Angeles (UCLA).
Dr. Bose has authored in excess of 120 peer-reviewed scientific articles and has been an invited speaker at more than 75 national and international meetings. Her research interests include cancerous and precancerous lesions of the breast and thyroid. She has been involved in several National Institutes of Health (NIH)-sponsored studies. She is a member of the College of American Pathologists Breast Cancer Protocol Review Panel and the American Joint Committee on Cancer – Breast Cancer Staging System and helped formulate the recommendations of the committee for breast cancer staging and diagnosis.
Board certified in anatomic pathology, Dr. Bose also holds special qualification in cytopathology. She is a regular reviewer for several journals. Dr. Bose is a member of numerous national and international organizations, particularly related to breast pathology and cytopathology.
Dr. Bose received her medical degree from King George’s Medical College, Lucknow, India and completed her pathology studies at the All India Institute of Medical Sciences in New Delhi. In the US she did a pathology residency at Lankenau Hospital in Philadelphia, as well as fellowships in cytopathology (Lankenau Hospital), surgical pathology (Memorial Sloan-Kettering Cancer Center in New York) and a two-year fellowship in breast pathology (Columbia Presbyterian Medical Center in New York City).
For more information please visit: www.alapio.org
